Serious adverse events are rare (reported from 3% to 10%), and include elevation of alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST), pyrexia, upper respiratory tract infection, and convulsions [20]. This evidence concerns the gene GPT and convulsion.